Your browser doesn't support javascript.
loading
Durable benefit of rituximab maintenance post-autograft in patients with relapsed follicular lymphoma: 12-year follow-up of the EBMT lymphoma working party Lym1 trial.
Pettengell, R; Uddin, R; Boumendil, A; Johnson, R; Metzner, B; Martín, A; Romejko-Jarosinska, J; Bence-Bruckler, I; Giri, P; Niemann, C U; Robinson, S P; Kimby, E; Schmitz, N; Dreger, P; Goldstone, A H; Montoto, S.
Afiliação
  • Pettengell R; Institute of Medical & Biomedical Education, St George's University of London, London, United Kingdom. r.pettengell@sgul.ac.uk.
  • Uddin R; EBMT Clinical Trials Office, European Society for Blood and Marrow Transplantation, London, United Kingdom.
  • Boumendil A; Statistics, European Society for Blood and Marrow Transplantation, Paris, France.
  • Johnson R; Department of Haematology, St James's University Hospital, Leeds, United Kingdom.
  • Metzner B; University Clinic for Internal Medicine, Oncology and Haematology, Klinikum Oldenburg, Oldenburg, Germany.
  • Martín A; Hematology Department, Hospital Universitario de Salamanca, IBSAL, CIBERONC, Salamanca, Spain.
  • Romejko-Jarosinska J; Department of Lymphoproliferative Diseases, Maria Sklodowska-Curie Memorial Institute and Oncology Center, Warsaw, Poland.
  • Bence-Bruckler I; The University of Ottawa, The Ottawa Hospital, Ottawa, Canada.
  • Giri P; Haematology, Royal Adelaide Hospital, Adelaide, Southern Australia, Australia.
  • Niemann CU; Department of Hematology, Rigshospitalet, Copenhagen, Denmark.
  • Robinson SP; Department of Haematology, University Hospitals Bristol NHS Foundation Trust, Bristol, United Kingdom.
  • Kimby E; Department of Hematology, Karolinska Institute, Stockholm, Sweden.
  • Schmitz N; Department of Internal Medicine A, University Hospital Muenster, Muenster, Germany.
  • Dreger P; Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
  • Goldstone AH; University College London Hospital, London, United Kingdom.
  • Montoto S; Department of Haemato-oncology, St Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.
Bone Marrow Transplant ; 56(6): 1413-1421, 2021 06.
Article em En | MEDLINE | ID: mdl-33452448
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma Folicular / Transplante de Células-Tronco Hematopoéticas Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Bone Marrow Transplant Assunto da revista: TRANSPLANTE Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Reino Unido